| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |